Clinical trials

Active, not recruiting clinical trials

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Phase: 2
Disease: Alopecia Universalis (AU), Alopecia Totalis (AT)
Location(s): United States, New York

Request more information about this clinical trial.

All fields required.
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)

Phase: 4
Disease: Seborrheic Keratosis
Location(s): Pennsylvania, Tennessee, Texas

Request more information about this clinical trial.

All fields required.
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

Phase: 2
Disease: Dermatosis Papulosa Nigra
Location(s): District of Columbia, New York

Request more information about this clinical trial.

All fields required.
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

Phase: 2
Disease: Androgenetic Alopecia
Location(s): Colorado, Oregon, Texas

Request more information about this clinical trial.

All fields required.

Recruiting clinical trials

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

Phase: 2
Disease: Alopecia Areata, Alopecia Totalis, Alopecia Universalis
Location(s): United States, Florida

Request more information about this clinical trial.

All fields required.
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Phase: 2
Disease: Alopecia Areata, Alopecia Universalis, Alopecia Totalis
Location(s):

Request more information about this clinical trial.

All fields required.
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

Phase: 2
Disease: vitiligo
Location(s):

Request more information about this clinical trial.

All fields required.
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Phase: 2
Disease: alopecia areata
Location(s):

Request more information about this clinical trial.

All fields required.
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

Phase: 2
Disease: Atopic Dermatitis
Location(s):

Request more information about this clinical trial.

All fields required.
THWART-1 Study of A-101 Topical Solution for the Treatment of Common Warts

THWART-1 Study of A-101 Topical Solution for the Treatment of Common Warts

Phase: 3
Disease: Common Wart
Location(s):

Request more information about this clinical trial.

All fields required.
THWART-2 A Study of A-101 Topical Solution for the Treatment of Common Warts

THWART-2 A Study of A-101 Topical Solution for the Treatment of Common Warts

Phase: 3
Disease: Common Wart
Location(s):

Request more information about this clinical trial.

All fields required.